Value of TTF‑1 expression in non‑squamous non‑small‑cell lung cancer for assessing docetaxel monothe...
Value of TTF‑1 expression in non‑squamous non‑small‑cell lung cancer for assessing docetaxel monotherapy after chemotherapy failure
About this item
Full title
Author / Creator
Takeuchi, Akira , Oguri, Tetsuya , Yamashita, Yoriko , Sone, Kazuki , Fukuda, Satoshi , Takakuwa, Osamu , Uemura, Takehiro , Maeno, Ken , Inoue, Yoshitsugu , Yamamoto, Sayaka , Nishiyama, Hirono , Fukumitsu, Kensuke , Kanemitsu, Yoshihiro , Tajiri, Tomoko , Ohkubo, Hirotsugu , Takemura, Masaya , Ito, Yutaka and Niimi, Akio
Publisher
Athens: Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Athens: Spandidos Publications
Subjects
More information
Scope and Contents
Contents
Docetaxel is one of the standard second/third-line treatments for non-small-cell lung cancer (NSCLC) following a failed response to prior cytotoxic chemotherapy. The predictive biomarker for the effectiveness of docetaxel therapy remains undetermined. However, thyroid transcription factor-1 (TTF-1) is known to be a good prognostic factor for a vari...
Alternative Titles
Full title
Value of TTF‑1 expression in non‑squamous non‑small‑cell lung cancer for assessing docetaxel monotherapy after chemotherapy failure
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7391830
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7391830
Other Identifiers
ISSN
2049-9450
E-ISSN
2049-9469
DOI
10.3892/mco.2020.2080
